Sure Hope It’s Less Expensive Than These New Inhalers
The Aerovance company reports good test results from two clinical trials with a new asthma drug, although some doctors are apparently skeptical.
Called a pitrakinra, the drug is a cytokine blocker. These kinds of drugs have been tried in the past, but the new one is different because it blocks two cytokines associated with asthma, while the older versions blocked only one.
According to the company, twenty years of research back the development of the drug and years of trials will take place before/if it ever hits the market in inhaled form.
You know, I read all the time about new clinical trials, new research, and new theories about asthma. It’s easy to get excited about a pharmaceutical that seems like it might offer real hope, but I know the reality is that for any chronic illness/disease/disorder, new advances and meds are few and far between.
If this one works, though, I could see how it would change the lives for thousands (tens of thousands?) of families. Researchers say the medicine would help asthmatics who don’t respond well to corticosteroid maintenance, and I honestly can’t picture my life if my kid were one of those unfortunates. Steady Flovent use changed Asthma Girl’s life, and mine as a result. I used to have an online friend on one of the older asthma message boards, and her preschooler used the highest dosages for all his meds without attaining good control. Stuff like this drug seems tailor-made for kids like him.
I hope it works. I hope, I hope, I hope.